HOLIDAY OFFICE CLOSURE
In observance of the Martin Luther King holiday, Cisive will be closed on Monday, January 17th.
DELAYS AND CLOSURES
We will begin to see delays with all services as we near the Christmas and New Year's Holiday. Many government agencies and education institutes close during this time and delays should be expected.
Closures and Delays:
- Massachusetts: Massachusetts MVRs will be unavailable Saturday, 1/22/22 from 12:00am CT to 5:00am CT.
- South Carolina: South Carolina MVRs will be unavailable on Sunday, 1/23/22 from 5:00pm CT to 9:00pm CT.
DRUG TESTING ALERT
Due to the COVID-19 surge and the impact of available labor, including national winter weather, our partner is experiencing delays in receiving and processing specimens.
What they are doing:
- We are working with our shipping partners and expanding our operating hours to lessen the impact on your business.
What to expect:
- Please anticipate extended turnaround times over the next few weeks.
- Negative test results may be delayed up to one day.
- Confirmation testing may be delayed up to seven days.
We will continue to monitor the situation and provide updates when new information is available.
Don’t hesitate to get in touch with your account representative for more information.
Our vendors continue to monitor laboratory delays and communicate any progress or remaining challenges. Please see the updated summary below for each of our main lab partners.
Quest reports negative specimens are reporting under 24 hours on average. Non-negative specimens are averaging 3 to 5 business days from time of receipt.
Collection kit fulfillment is still a challenge. They are still seeing about 25 to 30 days for orders to be received by the requestor. Quest reports CCF order fulfillment is back to standard turnaround times of 5 to 7 business days.
LabCorp's main lab in North Carolina continues to report extreme delays. As they continue to endure staffing challenges and work through an overwhelming influx of specimens, LabCorp is unable to provide a reporting ETA presently. While some non-negative specimens are being reported within 10 to 14 business days, others, specifically cotinine non-negative samples, are taking up to 30 business days to complete testing. Testing timetables restart each time the sample is requeued for testing. To combat this, LabCorp continues to mandate employee overtime and divert specimens to other LabCorp facilities for testing. However, with specimen rerouting, transit times are longer than usual.
We appreciate your patience during this time. We will continue to provide updates as changes occur.
Alere reports negative specimens are reporting on average of 24 to 48 hours. Non-negative specimens are averaging 6 to 8 days for completion.
Relating to products, Alere still maintains that due to global supply chain issues, they are adjusting some product orders to reflect client's current usage. This is being done to help manage inventory and meet the ordering needs of all their clients.
The Department of Homeland Security (DHS) and U.S. Immigration and Customs Enforcement (ICE) announced an extension of the flexibility in complying with requirements related to Form I 9, Employment Eligibility Verification, due to COVID 19.
This temporary guidance was set to expire Dec. 31, 2021. Because of ongoing precautions related to COVID 19, DHS has extended the Form I 9 requirement flexibility policy until April 30, 2022.
See the original ICE news release from March 20, 2020 for more information on how to obtain, remotely inspect, and retain copies of the identity and employment eligibility documents to complete Section 2 of Form I 9. Please also consult ICE’s guidance for clarification on this provision.
Employers must monitor the DHS and ICE's Workforce Enforcement announcements about when the extensions end and normal operations resume.
E Verify participants who meet the criteria and choose the remote inspection option should continue to follow current guidance and create cases for their new hires within three business days from the date of hire. Please see USCIS’s COVID 19 webpage for more information. If you have any questions or concerns, please contact your Client Success Representative.